View Profile

Sangita Mishra

Rearcher, Department of Pharmaceutics · JSS College of Pharmacy, Mysuru

https://researchid.co/smishra1990
@jssuni.edu.in
7Scopus Publications
53Google Scholar Citations
3Google Scholar h-index
1Google Scholar i10-index

Research Interests

Health Policy, Rare Diseases, Regulatory Science

Biography

I have completed my PhD research from JSS College of Pharmacy, Mysuru, India, specializing in Health Policy and Regulatory Sciences. I hold a Masters in Microbiology from Calcutta University. My research focuses on the clinical and regulatory aspects of orphan drugs, with a particular emphasis on global clinical trials, policies, regulations, and therapeutic management. My research has resulted in two international publications as the first author in the Orphanet Journal of Rare Diseases, exploring orphan drug trials in the EU and rare disease management in India. Additionally, I have co-authored several other publications on orphan drug pricing in the USA, pharmacoepidemiology, and regulatory aspects of therapeutics in various geographies. My ongoing studies include assessment of cell and gene therapy products usage and effectiveness for rare disease treatment in India and review of ongoing pharmacoepidemiological studies in India to inform health policy planning. I am keen in conti

Education

MSc, PhD

Recent Scopus Publications

  1. Regulatory Pathway for Genotoxic Impurities in Europe, US, Canada, India, Australia and UK
    Indian Journal of Pharmaceutical Education and Research, 2026
  2. Regulatory Prospects for Stem Cell in Clinical Trials: UAE, US, and India
    Current Stem Cell Research and Therapy, 2025
  3. Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges
    Orphanet Journal of Rare Diseases, 2024
  4. Navigating health policies and programs in India: exploring opportunities to improve rare disease management and orphan drug research
    Orphanet Journal of Rare Diseases, 2024
  5. Navigating the mammography quality standard act in USA: Role of US FDA and future scopes of regulation
    Journal of Medical Imaging and Radiation Sciences, 2024

Links